<amendment session="119" chamber="h" number="23" updated="2025-06-05T15:29:32Z">
  <amends type="h" number="2483" sequence=""/>
  <status datetime="2025-06-04T15:08:05-04:00">pass</status>
  <sponsor bioguide_id="B001327"/>
  <offered datetime="2025-06-04"/>
  <description>An amendment numbered 1 printed in Part A of House Report 119-130 to require all HHS regulations or guidance documentation to use language that is inclusive of all opioid overdose reversal drugs that have been approved by FDA, instead of referring to brand names.</description>
  <purpose/>
  <actions>
    <vote datetime="2025-06-04T15:08:05-04:00" how="by voice vote" result="pass">
      <text>On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote.</text>
    </vote>
    <action datetime="2025-06-04T15:05:11-04:00">
      <text>Amendment (A001) offered by Mr. Bresnahan.</text>
      <reference ref="CR H2453" label="consideration"/>
      <reference ref="CR H2453" label="text"/>
    </action>
    <action datetime="2025-06-04T15:05:11-04:00">
      <text>House Amendment Offered</text>
    </action>
    <action datetime="2025-06-04T15:08:05-04:00">
      <text>House amendment agreed to: On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote.</text>
    </action>
  </actions>
</amendment>
